Digital Health Global

NOVEMBER 20, 2023

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Healthcare IT News - Telehealth

JANUARY 20, 2022

Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. You predict that decentralization will become a major theme for health and life science organizations. Please elaborate.

Life Science 203

Life Science Primary Care Mental health Drug Development 203

Lloyd Price

NOVEMBER 16, 2024

The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services. These challenges include: High costs: Watson is expensive to develop and maintain.

Drug Development 73

Drug Development healthcare technology Leadership Life Science 73

Healthcare IT Today

JANUARY 7, 2025

Chris McSpiritt, Head of Life Sciences at Domino Data Lab Next year will see AI-enhanced imaging technologies significantly improve diagnostic accuracy in radiology and pathology, empowering clinicians to make quicker and more reliable decisions at the point of care. Today, it’s largely restricted to genomics and oncology.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Healthcare IT Today

FEBRUARY 24, 2025

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI Leverages Proprietary AI, Generative Computational Chemistry, and Best-in-Class Biology to Cut Drug Development Timelines and Costs, Transforming Cancer and Rare Disease Treatments Company Raises $24.6

Life Science 59

Life Science Drug Development Health IT Healthcare IT 59

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. It has been used in various studies in Europe with great results.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Healthcare IT Today

OCTOBER 6, 2023

This platform is designed to meet the demands of health systems and life science companies working to solve increasingly global, diverse, and data-intensive healthcare problems. Atropos’ unique global offerings help life science leaders overcome this challenge.

Life Science 124

Life Science Drug Development Pharmaceuticals Health IT 124

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 105

Life Science Drug Development Digital Health Health IT 105

Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Healthcare IT Today

JULY 20, 2023

We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.” “The Flywheel uses AI to unlock the value within medical imaging data, signaling the continued benefit of applying AI across the healthcare industry.”

Life Science 75

Life Science Drug Development Healthcare Innovation Pharmaceuticals 75

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. The unification of technology, services and pharmacovigilance expertise in the coming year will further enunciate the industry’s focus on patient safety. Dave Latshaw, CEO at BioPhy 1.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

Society for Participatory Medicine

JANUARY 27, 2022

The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. Contacts Isabella Morreale quanthealth@solcomms.co

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Healthcare IT Today

MAY 22, 2023

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

Life Science 69

Life Science Drug Development Health IT Healthcare IT 69

Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS Early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

The Digital Health Corner

MARCH 26, 2018

Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant. It can impact the opioid crisis and improve tracking drugs in the supply chain.

Digital Health 117

Digital Health Interoperability Life Science HIE 117

Healthcare IT Today

JULY 25, 2022

Cornerstone’s founders incubated the company in partnership with Initiate Studios, a new venture studio that co-creates companies at the intersection of healthcare, life sciences and technology. AI/ML is revolutionizing the healthcare industry,” said Schiess. Learn more at www.healthy.vc.

Life Science 98

Life Science Drug Development Digital Health Health Data 98

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” For more information, please visit www.avilar-tx.com and follow us on Twitter @Avilar_Tx and on LinkedIn.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.

Life Science 88

Life Science BioTech Drug Development Health science 88

Healthcare IT Today

NOVEMBER 14, 2022

Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 67

Pharmaceuticals Digital Health Drug Development Life Science 67

Digital Health Global

MAY 21, 2024

And the FNIH is bringing industry together with NIH, FDA, and nonprofit organizations to make it happen,” said Daniel Doctoroff, who is living with ALS and whose father and uncle passed away from the disease. ALS is a progressive and ultimately fatal neurological disease with few treatment options and no cure yet.

Life Science 88

Life Science Drug Development Digital Health Health Technology 88

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. One of the core issues is that the industry has become single threaded in its sourcing strategy. Check out our community’s pharma predictions.

Health IT 85

Health IT Pharmaceuticals Drug Development Life Science 85

Healthcare IT Today

JANUARY 17, 2024

Greg Wujek, Global Health Industry Consultant at SAS Robots as providers comes of age. The use of robots in health care will exponentially mature with the development of robots capable of performing basic medical tasks, such as taking vital signs, administering medications, and providing wound care.

Health IT 103

Health IT Mental health Interoperability Patient Experience 103